Literature DB >> 11916532

Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias.

M A Vos1, J M van Opstal, J D Leunissen, S C Verduyn.   

Abstract

When a new (cardiovascular) drug shows signs of QT interval prolongation on the ECG (delay in repolarization time), the regulatory agencies demand screening of its possible proarrhythmic potential before approving it for clinical practice. In this review, identified predisposing factors have been related to specific electrophysiological parameters, allowing quantification of their contribution to Torsade de Pointes arrhythmias. In addition, arrhythmogenic mechanisms involved in the initiation and perpetuation of drug-induced Torsade de Pointes are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11916532     DOI: 10.1016/s0163-7258(01)00162-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  12 in total

Review 1.  Drugs, QT interval prolongation and ICH E14: the need to get it right.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  T-wave morphology parameters based on principal component analysis reproducibility and dependence on T-offset position.

Authors:  Fabrice Extramiana; Abdeddayem Haggui; Pierre Maison-Blanche; Rémi Dubois; Seiji Takatsuki; Philippe Beaufils; Antoine Leenhardt
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

3.  ECG evaluation of ventricular properties: the importance of cardiac cycle length.

Authors:  Fabrice Extramiana; Antoine Leenhardt; Pierre Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

4.  The time course of new T-wave ECG descriptors following single- and double-dose administration of sotalol in healthy subjects.

Authors:  Fabrice Extramiana; Rémi Dubois; Martino Vaglio; Pierre Roussel; Gerard Dreyfus; Fabio Badilini; Antoine Leenhardt; Pierre Maison-Blanche
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

Review 5.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

6.  Limited role of Ca2+-activated Cl- current in early afterdepolarisations.

Authors:  A O Verkerk; H L Tan; T Baartscheer; J H Ravesloot
Journal:  Neth Heart J       Date:  2002-12       Impact factor: 2.380

7.  Evidence for gender differences in electrophysiological properties of canine Purkinje fibres.

Authors:  Najah Abi-Gerges; Ben G Small; Chris L Lawrence; Tim G Hammond; Jean-Pierre Valentin; Chris E Pollard
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

8.  Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations.

Authors:  Mitsunori Maruyama; Jianmin Xiao; Qiang Zhou; Kannan Vembaiyan; Su-Kiat Chua; Michael Rubart-von der Lohe; Shien-Fong Lin; Thomas G Back; S R Wayne Chen; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2012-09-14       Impact factor: 6.343

Review 9.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

Review 10.  Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability.

Authors:  M A Vos
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.